In a report released today, Andrew Mok CFA from Barclays maintained a Hold rating on Humana (HUM – Research Report), with a price target of ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Humana (HUM – Research Report) and Acumen Pharmaceuticals ...

This was the stock's fourth consecutive day of gains.

Humana Inc. can proceed with a lawsuit alleging two Texas medical equipment suppliers owe it about $2.8 million after filing ...

Valued at a market cap of $34.5 billion, Humana Inc. (HUM) is a health care plan provider that offers medical and specialty ...

Humana's stock has shown resilience, boosted by a 5% increase in Medicare Advantage payments. Read my analysis of HUM stock.

UnitedHealth Group Incorporated UNH and Humana Inc. HUM are two of the most prominent players in the U.S. health insurance ...

The healthcare stock at just under $282 per share and had been as much as 17% higher at the open, but till held onto most of ...

Investors are digesting tariff whiplash after the White House confirmed plans to levy 104% tariffs on China, set to go into ...

The 2024 Impact Report showcases Humana's impacts on communities, the dedication of employees and leaders, and how Humana is improving health outcomes through innovation and integrated care. The ...

Chip stocks rallied midday Tuesday, with Broadcom (AVGO) getting a particular boost after it authorized a $ ...

The Dow, S&P 500, and Nasdaq fell Tuesday, as the stock market's morning rally evaporated amid uncertainty around President Donald Trump's tariffs.